Identification and Treatment of the Liability to Develop Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
This study seeks to determine whether adult, non-psychotic, first-degree relatives of schizophrenic patients who show specific neurocognitive deficits and negative symptoms will show improvements in these areas following a 6-month, double-blind trial of a low dose (up to 2.0 mg) of risperidone.
Epistemonikos ID: 465e31d948b52b89e84f64ab74461f504ec71adc
First added on: May 04, 2024